Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Patient Satisfaction 2Urologic Neoplasms 1Thyroid Cancer, Papillary 1Radiation Injuries 1Patient Preference 1Patient Acceptance of Health Care 1Neoplasms 1Breast Neoplasms 1

Interventions

delta 24-sterol reductase 1daratumumab 1Validation Studies as Topic 1Tape Recording 1Sorafenib 1Pilot Projects 1Focus Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Patient Preference × delta 24-sterol reductase × Clear all
NCT05236218 2023-03-08

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

King's College London

Unknown
60 enrolled

Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡